Get started
Author

Вольхин Никита Николаевич

Observed names: N. N. Volkhin, N. Volkhin, NN Volkhin, Nikita N. Volkhin, Вольхин Н. Н., Вольхин Н.Н., Н. Н. Вольхин
ORCID: 0000-0002-4275-9037
Observed ORCID: 0000-0002-4275-9037
OpenAlex ID: A5026489459
Pharmacological Properties of Sulfonamide Derivatives, New Inhibitors of Carbonic Anhydrase
2023 · A. L. Khokhlov, A. A. Shetnev, et al. · Bulletin of Experimental Biology and Medicine · 10
Screening of anti-inflammatory activity of 4.5-dihydroisoxazol-5-carboxamide (PAR-2 inhibitors) based on formaldehyde oedema model among white lab rats
2023 · Mikhail K. Korsakov, Vladimir N. Fedorov, et al. · Research Results in Pharmacology · 7
PDF
Development of quantification methods of a new selective carbonic anhydrase II inhibitor in plasma and blood and study of the pharmacokinetics of its ophthalmic suspension in rats
2023 · Alexander L. Khokhlov, Ilya I. Yaichkov, et al. · Research Results in Pharmacology · 7
PDF
Pharmacological properties of sulfonamide derivatives — new inhibitors of carbonic anhydrase
2023 · A. L. Khokhlov, A. A. Shetnev, et al. · Bulletin of Experimental Biology and Medicine · 7
The evaluation of pharmacokinetic parameters of 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide and its metabolites in rat plasma
2024 · Alexander L. Khokhlov, Ilya I. Yaichkov, et al. · Research Results in Pharmacology · 5
PDF
Identification and synthesis of metabolites of the new antiglaucoma drug
2023 · Alexander L. Khokhlov, Ilya I. Yaichkov, et al. · Research Results in Pharmacology · 5
PDF
Pharmacokinetic study of a new 4,5-dihydroisoxazole-5-carboxamide derivative in rats
2024 · I. I. Yaichkov, M. K. Korsakov, et al. · Drug development & registration · 4
PDF
Excretion Study of 5-[5-(Trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide in Rats
2025 · I. I. Yaichkov, A. L. Khokhlov, et al. · Ведомости Научного центра экспертизы средств медицинского применения · 3
PDF
Identification and synthesis of metabolites of the new 4.5-dihydroisoxazol-5-carboxamide derivate
2024 · Alexander L. Khokhlov, Ilya I. Yaichkov, et al. · Research Results in Pharmacology · 3
Development and validation of a method for the quantitative determination of monoamine neurotransmitters and their metabolites in rat brain tissue using HPLC-MS/MS
2024 · A. L. Khokhlov, I. I. Yaichkov, et al. · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · 3
PDF
Carbonic anhydrase inhibitors for the treatment of glaucoma
2023 · VV Strakhov, MK Korsakov, et al. · Медицинская этика · 3
PDF
Identification and synthesis of metabolites of 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide
2024 · Alexander L. Khokhlov, Ilya I. Yaichkov, et al. · Research Results in Pharmacology · 2
PDF
Development and validation of the method of quantification of 5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide and its metabolites in laboratory animal plasma
2024 · I. I. Yaichkov, M. K. Korsakov, et al. · Drug development & registration · 2
PDF
Pharmacokinetics Study of a New Isoxazole Derivative in Rats Using HPLC-MS/MS for Blood Sample Analysis
2024 · I. I. Yaichkov, A. L. Khokhlov, et al. · Ведомости Научного центра экспертизы средств медицинского применения · 1
PDF
Experimental study of organ‑protective activity of peptide drugs under intoxication induced by a combination of first‑line antituberculosis agents
2026 · N. A. Smirnov, S. V. Kulikov, et al. · Patient-Oriented Medicine and Pharmacy
Modern Approaches to the Pharmacological Treatment of Parkinson's Disease
2026 · V. Fedorov, V. Vdovichenko, et al. · Problems of Biological Medical and Pharmaceutical Chemistry
The excretion study of 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide in rats
2025 · Alexander L. Khokhlov, Ilya I. Yaichkov, et al. · Research Results in Pharmacology
PDF
The study of distribution of a new 4,5-dihydroisoxazole-5-carboxamide derivative in rats
2025 · I. I. Yaichkov, M. K. Korsakov, et al. · Drug development & registration
PDF
The study of relative bioavailability of ocular suspension of 4-(5-methyl-1,3,4 oxadiazole-2-yl)-benzenesulfonamide in rabbits
2025 · II Yaichkov, NN Volkhin, et al. · Медицинская этика
PDF
The study of systemic exposition of 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide in blood on rats
2025 · Alexander L. Khokhlov, Ilya I. Yaichkov, et al. · Research Results in Pharmacology
PDF
Experimental evaluation of osteogenic activity of certain hormonal drugs
2025 · Nikolay A. Smirnov, Nikita N. Volkhin, et al. · Research Results in Pharmacology
PDF
Distribution Study of 5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide and Its Metabolites in Rats
2025 · I. I. Yaichkov, A. L. Khokhlov, et al. · Ведомости Научного центра экспертизы средств медицинского применения
The excretion study of a new derivative of 4,5-dihydroisoxazole-5-carboxamide
2025 · I. I. Yaichkov, M. K. Korsakov, et al. · Drug development & registration
Antiparkinsonian activity of selective MAO-B inhibitors of different chemical structures.
2024 · Vladimir N. Fedorov, Mikhail K. Korsakov, et al. · Research Results in Pharmacology
PDF
Antirheumatic activity of 3-imidazole-substituted-4,5-diaryloisoxazol-3-carboxylic acid amide derivative, a proteinase inhibitor-activated type II receptor
2024 · VN Fedorov, MK Korsakov, et al. · Медицинская этика
PDF
Works count: 34
Citation count: 62
H-index: 5
I10-index: 1
Year
Topic
Type